학술논문
Impact of personalized diabetes care on distress and treatment satisfaction in people with breast cancer.
Document Type
Article
Author
Source
Subject
*TREATMENT of diabetes
*PSYCHOLOGICAL distress
*GLYCOSYLATED hemoglobin
*RESEARCH funding
*BREAST tumors
*PILOT projects
*QUESTIONNAIRES
*TREATMENT effectiveness
*HYPOGLYCEMIC agents
*SURVEYS
*PATIENT-centered care
*TELEMEDICINE
*CONTINUOUS glucose monitoring
*CANCER patient psychology
*INDIVIDUALIZED medicine
*PATIENT satisfaction
*HEALTH outcome assessment
*DATA analysis software
*BLOOD sugar monitoring
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
0742-3071
Abstract
Aims: In patients with breast cancer (BCa) and diabetes (DM), diabetes distress (DD) and treatment satisfaction (DTS) can influence BCa management and outcomes. We assessed the impact of implementing a personalized diabetes care model in patients with BCa. Methods: Patients in active treatment or surveillance for BCa with an HbA1c > 53 mmol/mol (7%) or random blood glucose >11.1 mmol/L were included. Participants were offered continuous glucose monitoring (CGM), virtual care and a dedicated diabetes provider for 6 months. Primary outcomes included DD measured by the Diabetes Distress Survey (DDS) and DTS measured by the Diabetes Treatment Satisfaction Questionnaire (DTSQ). Questionnaires were conducted at 0, 3 and 6 months. Results: Thirty‐one women were enrolled (median age 61, IQR 49.0–69.0). Compared to baseline, the mean DDS score was lower at both 3 months (2.2 vs. 1.8 [n = 27], p = 0.004, SD = 0.70) and 6 months (2.3 vs. 1.8 [n = 23], p = 0.002, SD = 0.70). The mean DTSQ score was higher at 3 months (baseline: 20.5 vs. 3 months: 28.7 [n = 28], p < 0.001, SD = 9.2) and 6 months (baseline: 20.4 vs. 6 months: 30.0 [n = 26], p < 0.001, SD = 9.7). Conclusions: Personalized diabetes care models that emphasize remote management and optimize access for those with BCa may lower DD and improve DTS. [ABSTRACT FROM AUTHOR]